Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Magnesium Sulfate vs Dexmedetomidine as Adjuvants to Bupivacaine in OSCTAP Block for Laparoscopic Cholecystectomy
NCT06743919Phase 4Completed
- Sponsor
- Assiut University
- Start
- Jan 2025
- Primary completion
- Jan 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of magnesium sulfate and dexmedetomidine in postoperative pain (3 arms), sponsored by Assiut University. Primary endpoint: Total Postoperative Analgesic Consumption at 24 hours. Started Jan 2025; status: completed.
02
Drugs
magnesium sulfatedexmedetomidine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT06743919.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06743919.